Investment Rating - The report maintains an "Overweight" rating for the construction materials industry [1]. Core Views - The real estate chain is expected to see a valuation recovery in 2026, with a potential rebound driven by policy expectations and market dynamics [2]. - The report highlights several sectors for investment focus, including high-dividend stocks, export-oriented industries, and home improvement consumption [2]. - The technology sector is emphasized, particularly in domestic semiconductor development and AI applications, which are projected to grow rapidly [2]. - The report indicates that the performance of the real estate chain remains subdued, but cost-cutting measures are showing positive effects [2]. - The global trade environment is expected to stabilize, with fiscal expansion in major economies supporting sectors like AI and innovative pharmaceuticals [2]. Summary by Sections 1. Construction Materials Fundamentals and High-Frequency Data - Cement prices remain stable at 347.7 CNY/ton, unchanged from the previous week but down 52.2 CNY/ton year-on-year [6][15]. - The average cement inventory ratio is 59.4%, up 0.5 percentage points from last week and up 3.1 percentage points from the same period last year [23]. - The average cement shipment rate is 29.5%, down 10.4 percentage points from last week but up 16.1 percentage points year-on-year [23]. 2. Industry Dynamics Tracking - The report notes that the cement industry is undergoing supply-side adjustments, with a focus on eliminating outdated capacity [10]. - The glass market is experiencing price stability, with average prices for float glass at 1138.8 CNY/ton, reflecting a slight increase from the previous week but a significant decrease from last year [46]. - The fiberglass sector is expected to see stable demand growth, particularly in wind power and new applications, with effective capacity projected to increase by 6.9% in 2026 [10]. 3. Weekly Market Review and Sector Valuation - The construction materials sector saw a weekly increase of 9.23%, outperforming the Shanghai and Shenzhen 300 index [6]. - The report suggests that the valuation of leading companies in the construction materials sector is at historical lows, indicating potential for recovery as industry policies take effect [10]. - Recommendations include companies like China National Building Material and Conch Cement, which are expected to benefit from improved industry dynamics and overseas market expansion [10].

Investment Rating - The report maintains an "Accumulate" rating for the power equipment industry [1] Core Viewpoints - The space for space photovoltaic technology is vast, and the potential for solid-state batteries and AIDC (Advanced Intelligent Driving Control) is promising [1] - The energy storage sector is expected to see significant growth, with a projected increase of over 60% in 2026 due to rising demand and supply constraints [3][4] - The report highlights the strong performance of various segments within the power equipment industry, including wind power, nuclear power, and lithium batteries, with notable price increases in lithium carbonate and other materials [3][4] Industry Trends - The energy storage market in China is experiencing rapid growth, with new installations reaching 66.43 GW and 189.48 GWh in 2025 [3] - The report notes that the U.S. energy storage market is also expanding, with a projected installation of 80 GWh in 2026, driven by data center demands and favorable policies [7] - The report indicates that the demand for solid-state batteries is increasing, with major companies accelerating their production lines [4] Company Performance - Companies such as Ningde Times, Sunshine Power, and others are expected to see significant profit growth in 2025, with projected increases ranging from 50% to over 100% [3][4] - The report mentions specific companies like Hunan YN, which anticipates a net profit of 1.15-1.4 billion yuan in 2025, reflecting a year-on-year increase of 93.75%-135.87% [3] - The report also highlights the expected losses for companies like Longi Green Energy and Tongwei Co., with projected net losses of 6-6.5 billion yuan and 9-10 billion yuan, respectively [3] Investment Strategy - The report suggests a focus on energy storage, lithium batteries, and solid-state technologies, with recommendations for leading companies in these sectors [4] - It emphasizes the importance of companies with strong technological advantages and overseas market access, particularly in the AIDC sector [4] - The report also highlights the potential for growth in the wind and solar power sectors, with specific recommendations for companies involved in these areas [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's Q4 performance is in line with market expectations, with a projected net profit attributable to shareholders of 0.62 to 0.86 billion yuan, representing a year-on-year increase of 51% to 109% [9] - The company achieved a total shipment of approximately 4.1 GWh in 2025, a year-on-year increase of 170%, with significant growth in energy storage and breakthroughs in light-duty power businesses [9] - The unit profitability slightly declined in Q4 due to rising raw material prices, but is expected to improve gradually as production capacity utilization increases [9] - The company forecasts net profits of 0.75 billion yuan in 2025, 5.2 billion yuan in 2026, and 8.4 billion yuan in 2027, with corresponding P/E ratios of 210x, 31x, and 19x [9] Financial Summary - Total revenue for 2023 is projected at 3,299 million yuan, with a year-on-year decrease of 45.13% [1] - The net profit attributable to shareholders for 2023 is estimated at 515.64 million yuan, down 59.49% year-on-year [1] - The earnings per share (EPS) for 2023 is expected to be 2.10 yuan, with a significant drop in 2024 to 0.17 yuan [1] - The company anticipates a substantial increase in revenue in 2025 to 3,727 million yuan, with a year-on-year growth of 85.89% [1]

Investment Rating - The report maintains an "Accumulate" rating for the power equipment industry [1] Core Insights - The report highlights the vast potential of space photovoltaic technology and the promising prospects of solid-state batteries and AIDC (Automated Identification and Data Capture) [1] - The energy storage sector is expected to see significant growth, with a projected increase of over 60% in 2026 due to rising demand and supply constraints [3][4] - The report emphasizes the strong performance of various segments within the power equipment industry, including wind power, nuclear power, and lithium batteries, with notable price increases in lithium carbonate and other materials [3][4] Industry Trends - The energy storage market in China is experiencing rapid growth, with new installations reaching 66.43 GW and 189.48 GWh in 2025 [3] - The report notes that the U.S. energy storage market is also booming, with a projected installation of 80 GWh in 2026, driven by AI and data center demands [7] - The report indicates that the wind power sector is expected to grow significantly, with domestic offshore wind capacity projected to exceed 8 GW in 2025 [4] Company Performance - Companies such as Ningde Times, Sunshine Power, and others are expected to see substantial profit growth in 2025, with Ningde Times projected to achieve a net profit of 11.5-14 billion yuan, representing a year-on-year increase of 93.75%-135.87% [3][4] - The report highlights several companies with strong growth potential, including Ningde Times, Sunshine Power, and others, which are positioned well in the energy storage and electric vehicle markets [4][6] Investment Strategy - The report suggests a focus on energy storage, solid-state batteries, and AIDC technologies, with recommendations for leading companies in these sectors [4][6] - It emphasizes the importance of investing in companies with strong technological advantages and overseas market access, particularly in the context of rising global demand for energy storage solutions [4][6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company's Q4 performance is in line with market expectations, with a projected net profit attributable to shareholders of 0.62 to 0.86 billion yuan, representing a year-on-year growth of 51% to 109% [9] - The company achieved a total shipment of approximately 4.1 GWh in 2025, a year-on-year increase of 170%, with significant growth in energy storage and breakthroughs in light-duty power businesses [9] - The unit profitability slightly decreased in Q4 due to rising raw material prices, but is expected to improve gradually as production capacity utilization increases [9] - The company forecasts net profits of 0.75 billion yuan in 2025, 5.2 billion yuan in 2026, and 8.4 billion yuan in 2027, with corresponding P/E ratios of 210x, 31x, and 19x [9] Financial Performance Summary - Total revenue for 2023 is projected at 3,299 million yuan, with a year-on-year decrease of 45.13% [1] - The net profit attributable to shareholders for 2023 is estimated at 515.64 million yuan, down 59.49% year-on-year [1] - The earnings per share (EPS) for 2023 is expected to be 2.10 yuan, with a significant drop in 2024 to 0.17 yuan [1] - The company anticipates a substantial increase in revenue and net profit in the following years, with revenue reaching 11,602 million yuan and net profit of 843.72 million yuan by 2027 [1]

证券研究报告 智能汽车主线周报： 特斯拉推出无安全员Robotaxi服务，看好智能化 注：若无特殊说明，"本周"均代表2026.1.19-2026.1.25 2 ◼ 本周智能汽车行情复盘：我们编撰的智能汽车指数+2.8%，智能汽车指数（除特斯拉）-1.4%。截至2026年 1月23日，智能汽车指数PS(TTM）为14.0x，该估值位于2023年初以来97%分位数；智能汽车指数（除特 斯拉）PS(TTM）为6.8x，该估值位于2023年初以来94%分位数。智能汽车指数标的池中中国汽研、浙江世 宝-H、佑驾创新、经纬恒润、四维图新涨幅前五。 （ ◼ 本周行业核心变化：1） 《广东省人工智能赋能交通运输高质量发展若干政策措施》出台，确认南沙的全域 自动驾驶突破；2）特斯拉推出无安全员Robotaxi服务，Cybercab已抵达纽约布法罗进行冬季测试；3）轻 舟智航：公布了自动驾驶技术、量产NOA辅助驾驶的最新成绩，还发布了全新轻舟乘风解决方案、L4自动驾 驶开放平台及 L4无人物流业务等；4）北美Robotaxi最新跟踪：2026年1月23日特斯拉可发现车队225辆， 截至2026年1月23日，FSD里程数共计73 ...

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [67]. Core Insights - The report highlights significant price fluctuations in the chemical sector due to extreme weather conditions affecting natural gas prices in the U.S. [1]. - The average prices for various chemical products, including pure MDI, polymer MDI, and TDI, have shown a decline compared to the previous week, with respective price changes of -129, -114, and -213 CNY/ton [2]. - The report provides a detailed analysis of profit margins across different segments, indicating a decrease in margins for pure MDI and polymer MDI, while TDI margins remained relatively stable [2]. Summary by Sections 2.1 Basic Chemical Index Trends - The basic chemical index has shown a weekly increase of 7.3% as of January 23, 2026, with a year-to-date increase of 16.8% [8]. 2.2 Polyurethane Sector - The average prices for pure MDI, polymer MDI, and TDI are reported at 17,714, 13,900, and 13,975 CNY/ton respectively, with corresponding profit margins of 4,503, 1,689, and 2,459 CNY/ton [2][16]. 2.3 Oil, Coal, and Olefin Sector - Ethane and propane prices have increased by 210 and 21 CNY/ton respectively, while the average price for coal remains stable at 520 CNY/ton [2][22]. - The average price for polyethylene is reported at 7,100 CNY/ton, showing a slight decrease of 15 CNY/ton [2][28]. 2.4 Coal Chemical Sector - The average prices for synthetic ammonia, urea, DMF, and acetic acid are 2,211, 1,740, 3,894, and 2,600 CNY/ton respectively, with minor fluctuations in profit margins [2][41]. 2.5 Animal Nutrition Sector - The average prices for VA, VE, solid egg, and liquid egg are reported at 62.2, 54.5, 17.6, and 14.2 CNY/kg respectively, with minimal changes observed [2][54].

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [173]. Core Insights - The report highlights that the geopolitical tensions between the U.S. and Iran are supporting international oil prices, with Brent and WTI crude oil futures averaging $64.8 and $60.1 per barrel, respectively, showing a slight increase of $0.1 and a decrease of $0.1 from the previous week [2]. - U.S. crude oil production is reported at 13.73 million barrels per day, with a slight decrease of 20,000 barrels per day week-on-week, while active oil rigs increased by 1 to 411 [2]. - The report recommends several companies for investment, including China National Offshore Oil Corporation (CNOOC), China Petroleum & Chemical Corporation (Sinopec), and China National Petroleum Corporation (PetroChina) [3]. Summary by Sections 1. Weekly Oil Data Brief - The report provides a comprehensive overview of weekly oil data, including price trends, inventory levels, production rates, and import/export statistics [5][7][8]. 2. Oil and Petrochemical Sector Performance - The oil and petrochemical sector has shown varied performance, with specific companies experiencing significant fluctuations in stock prices over the past week, month, and year [21][22]. 3. Crude Oil Data Tracking - Crude oil prices have been tracked, showing fluctuations in both Brent and WTI prices, alongside inventory levels and production data [25][26][37]. - U.S. crude oil inventories have increased, with total inventories reported at 840 million barrels, reflecting a week-on-week increase of 441,000 barrels [2][44]. 4. Refined Oil Data Tracking - The report details refined oil prices, inventory levels, production, and consumption trends, indicating a decrease in refinery throughput to 16.6 million barrels per day, down by 350,000 barrels per day [4][74]. - Refined oil inventories have also seen changes, with gasoline and diesel inventories increasing by 598,000 and 335,000 barrels, respectively [2][108]. 5. Oil Service Sector Data Tracking - The oil service sector is analyzed, focusing on the average day rates for drilling rigs and the overall performance of service companies [158][161].

Investment Rating - The report maintains a "Buy" rating for the pharmaceutical and biotechnology sector, specifically highlighting companies like Yuyuan Pharmaceutical and CanSino Biologics for their promising developments in mRNA vaccines [1]. Core Insights - The mRNA vaccine sector is experiencing a breakthrough, with mRNA technology leading the shift towards efficient and personalized immunotherapy. This technology offers three core competitive advantages: rapid production capabilities, enhanced safety profiles, and flexibility in antigen design, which supports personalized treatment approaches [1][4]. - The report identifies a favorable ranking of sub-industries, with innovative drugs, research services, and CXO services being prioritized for investment. High-yield sectors include traditional Chinese medicine and pharmacies [10][11]. - Specific companies are recommended for investment based on various therapeutic angles, including PD1 PLUS, ADC, and small nucleic acids, with notable mentions such as Innovent Biologics, CanSino Biologics, and Yuyuan Pharmaceutical [10][12][13]. Summary by Sections Market Performance - The A-share pharmaceutical index has shown a year-to-date increase of 6.66%, outperforming the CSI 300 index by 5.10%. The Hang Seng Biotechnology Index has also seen a 12.40% increase [4][9]. - Sub-sectors such as pharmaceutical commerce (+4.26%) and raw materials (+2.41%) have performed well, while bioproducts and chemical pharmaceuticals have faced declines [4][9]. Clinical Developments - Corcept Therapeutics has reported positive results from its Phase III trial for relacorilant, indicating survival benefits for patients with platinum-resistant ovarian cancer. Meanwhile, Maiwei Biologics has initiated its first patient dosing in the U.S. for its CDH17-ADC innovative drug [1][4]. Investment Recommendations - The report suggests a diversified investment approach across various therapeutic areas, including: - PD1 PLUS: Focus on companies like 3SBio and Innovent Biologics - ADC: Companies such as InnoCare Pharma and Kintor Pharmaceutical - Small nucleic acids: Recommendations include Frontier Biotechnologies and Yuyuan Pharmaceutical - Traditional Chinese medicine: Companies like Zhaoke Pharmaceutical and Fangsheng Pharmaceutical are highlighted [10][12][13]. Fund Holdings - The report notes a decrease in the proportion of public fund holdings in the pharmaceutical sector, with a total holding of 6.67% as of Q4 2025, down 1.46 percentage points from the previous quarter [17][18]. Company Performance - Specific companies have been highlighted for their market performance, with notable increases in stock prices for companies like *ST Changyao (+70.37%) and Hualan Biological (+32.21%) [9]. This comprehensive analysis provides insights into the current state and future potential of the pharmaceutical and biotechnology industry, emphasizing the importance of mRNA technology and strategic investment in key companies.

Investment Rating - The report maintains an "Overweight" rating for the retail industry [1] Core Insights - Mingming Hen Mang is the largest leisure food and beverage retail chain in China, formed by the merger of "Snacks Are Busy" and "Zhao Yiming Snacks" in November 2023, aiming to address industry pain points through scale procurement and efficient turnover [4][9] - The company is projected to achieve a revenue of CNY 39.34 billion and a net profit of CNY 0.83 billion in 2024, with nearly 15,000 stores [4][10] - The leisure food industry is experiencing rapid growth, with Mingming Hen Mang's revenue increasing from CNY 4.286 billion in 2022 to CNY 39.344 billion in 2024, representing a year-on-year growth of 282.17% [10][13] - The gross margin is expected to improve from 7.45% in 2022 to 9.73% in Q1-Q3 2025, while the net profit margin is projected to rise from 1.67% to 3.36% in the same period [10][16] - The report highlights the acceleration of brand consolidation in the snack retail sector, with the top five chain retailers contributing CNY 2.1 trillion in GMV, accounting for 57.1% of the food and beverage industry [17][20] Summary by Sections Industry Trends - The retail sector is witnessing a significant increase in store numbers, with major players like Mingming Hen Mang and Wancheng Group expanding aggressively across the country [23] - The competitive landscape is stabilizing with Mingming Hen Mang and Wancheng Group leading the market, holding over 70% of the market share in the snack retail sector [17][23] Financial Performance - Mingming Hen Mang's revenue and net profit for 2022, 2023, and 2024 are reported as follows: CNY 4.286 billion, CNY 10.295 billion, and CNY 39.344 billion for revenue; CNY 0.72 billion, CNY 2.17 billion, and CNY 8.34 billion for net profit, respectively [10][13] - The company achieved a revenue of CNY 46.371 billion in Q1-Q3 2025, surpassing the total revenue of 2024, with a year-on-year growth of 75.21% [10][13] Market Position - In 2024, Mingming Hen Mang's GMV reached CNY 55.5 billion, securing a market share of 1.5%, making it the largest leisure food and beverage retail chain in China [17][20] - The report suggests that investors should actively consider opportunities in the snack retail sector, especially with Mingming Hen Mang's upcoming H-share listing on January 28 [17][24]